chr11-17387407-C-T
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_000525.4(KCNJ11):c.685G>A(p.Glu229Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely risk allele (★★).
Frequency
Consequence
NM_000525.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCNJ11 | NM_000525.4 | c.685G>A | p.Glu229Lys | missense_variant | Exon 1 of 1 | ENST00000339994.5 | NP_000516.3 | |
KCNJ11 | NM_001166290.2 | c.424G>A | p.Glu142Lys | missense_variant | Exon 2 of 2 | NP_001159762.1 | ||
KCNJ11 | NM_001377296.1 | c.424G>A | p.Glu142Lys | missense_variant | Exon 3 of 3 | NP_001364225.1 | ||
KCNJ11 | NM_001377297.1 | c.424G>A | p.Glu142Lys | missense_variant | Exon 2 of 2 | NP_001364226.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 67
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Type 2 diabetes mellitus Pathogenic:1
Mutations in KCNJ11 gene can cause decreased production and secretion of insulin. This can lead to MODY which may be responsive to oral sulfonylureas. rs587783673 (p.Glu229Lys) of KCNJ11 is specifically associated with Neonatal Diabetes Mellitus. -
Diabetes mellitus, permanent neonatal 2 Pathogenic:1
The missense variant c.685G>A (p.Glu229Lys) in KCNJ11 gene has been reported in literature with nenontal diabetes mellitus (Orío Hernández M et.al.,2008). Functional studies for this variant has been done(Girard CA et.al.,2006). The variant has been reported to the ClinVar database as Pathogenic. The p.Glu229Lys variant is novel (not in any individuals) in gnomAD Exomes and 1000 Genomes. The amino acid Glu at position 229 is changed to a Lys changing protein sequence and it might alter its composition and physico-chemical properties. The variant is predicted to be damaging by both SIFT and PolyPhen2. The residue is conserved across species. The amino acid change p.Glu229Lys in KCNJ11 is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. For these reasons, this variant has been classified as Pathogenic -
Diabetes mellitus Pathogenic:1
- -
not provided Pathogenic:1
This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 229 of the KCNJ11 protein (p.Glu229Lys). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with autosomal dominant transient neonatal diabetes mellitus and/or clinical features of KCNJ11-related conditions (PMID: 17327377, 18559200, 22619292, 23462667, 26839896, 28350539, 28766502, 32418263, 32792356, 33852230, 34566892). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 158683). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt KCNJ11 protein function. Experimental studies have shown that this missense change affects KCNJ11 function (PMID: 17021801). For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at